Using the same expertise they’ve employed to build new organs for patients, scientists at Wake Forest Institute for Regenerative Medicine and colleagues have engineered micro hearts, lungs and livers that can potentially be used to test new drugs. By combining the micro-organs in a monitored system, the researchers aim to mimic how the human body responds to medications.
The goal of the effort, known as a “body-on-a-chip,” is to help reduce the estimated $2 billion price tag and 90 percent failure rate that pharmaceutical companies face when developing new medications. Drug compounds are currently screened in the lab using human cells and then tested in animals. But neither of these methods adequately replicates how drugs affect human organs.
“There is an urgent need for improved systems to accurately predict the effects of drugs, chemicals and biological agents on the human body,” said Anthony Atala, M.D., director of the institute and senior researcher on the multi-institution body on a chip project, funded by the Defense Threat Reduction Agency.
In Scientific Reports, published by Nature, the research team reports success engineering micro-sized 3D organs, known as organoids, and connecting them together on a single platform to monitor their function. While other teams have combined cells from multiple organs in a similar system, this is the first reported success using 3D organ structures, known to be higher functioning and to more accurately model the human body.
The organ structures were made from cell types found in native human tissue using 3D printing and other methods. Heart and livers were selected for the system because toxicity to these organs is a major reason for drug candidate failures and drug recalls. Lungs are the point of entry for toxic particles and also for aerosol drugs, such as asthma inhalers.
The organoids are placed in a sealed, monitored system – complete with real-time camera. A nutrient-filled liquid that circulates through the system keeps the organoids alive and is used to introduce potential drug therapies into the system.
The researchers first tested the organoids to ensure their similarity to human organs. For example, the micro-liver received a high dose of a common pain reliever – and then a different drug to counteract the toxic effects.
“The data show a significant toxic response to the drug as well as mitigation by the treatment, accurately reflecting the responses seen in human patients,” said Aleks Skardal, Ph.D., assistant professor at Wake Forest Institute for Regenerative Medicine, who represented the multi-investigator team as the lead author of the paper.
But more important than how an individual organ responds to drugs is how the body as a whole responds. In many cases during testing of new drug candidates – and sometimes even after the drugs have been approved for use – drugs have unexpected toxic effects in tissues not directly targeted by the drugs themselves.
“If you screen a drug in livers only, for example, you’re never going to see a potential side effect to other organs,” said Skardal. “By using a multi-tissue organ-on-a-chip system, you can hopefully identify toxic side effects early in the drug development process, which could save lives as well as millions of dollars.”
The scientists conducted multiple scenarios to ensure that the body-on-a- chip system mimics a multi-organ response. For example, they introduced a drug used to treat cancer into the system. Known to cause scarring of the lungs, the drug also unexpectedly affected the system’s heart. However, a control experiment using only the heart showed no response.
The scientists theorize that the drug caused inflammatory proteins from the lung to be circulated throughout the system. As a result, the heart increased beats and then later stopped altogether, indicating a toxic side effect.
“This was completely unexpected, but it’s the type of side effect that can be discovered with this system in the drug development pipeline,” Skardal said.
Scientists are working to increase the speed of the system for large scale screening, and also to add additional organs.
“Eventually we expect to demonstrate the utility of a body-on-a-chip system containing many of the key functional organs in the human body,” said Atala. “This system has the potential for advanced drug screening and also to be used in personalized medicine – to help predict an individual patient’s response to treatment.”
Learn more: Scientists Develop “Body-on- a-Chip” System to Accelerate Testing of New Drugs
The Latest on: Body-on-a-chip
[google_news title=”” keyword=”body-on-a-chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Infinix GT 20 Pro launched with 144Hz AMOLED display, Dimensity 8200, dedicated gaming chipon April 27, 2024 at 10:09 pm
The Infinix GT 20 Pro gaming phone has gone official in Saudi Arabia. The successor to last year’s GT 10 Pro offers a refined version of the Cyber Mecha design, featuring a C-shaped RGB-light design.
- ICEA bats for chip design, manufacturing to be treated as strategic sectoron April 25, 2024 at 10:45 am
Industry body ICEA has recommended various measures, including encouraging large Indian corporates to invest in semiconductor design and treating chip design and manufacturing as a strategic sector, ...
- Treat semiconductor chip manufacturing as a strategic sector: ICEAon April 25, 2024 at 3:20 am
ICEA, in its report, emphasised the critical need to develop a holistic design ecosystem encompassing the entire electronics value chain.
- ICEA shares blueprint for India to become a global leader in chip value chainon April 25, 2024 at 3:18 am
As India embarks on its ambitious semiconductor journey, providing strategic support for chip design firms, bridging the skill gap, enhancing funding mechanisms, leveraging global opportunities and ...
- Nvidia's Moat Remains Unchallenged Despite Emerging Players' Advanced AI Chipson April 24, 2024 at 8:05 pm
Upstart's focus on AI-specific chip efficiency might outperform Nvidia’s broader approach. Read why NVDA stock is a Buy despite challenges.
- Micron: CHIP Grants Are Rocket Fuel (Rating Upgrade)on April 24, 2024 at 9:41 am
Micron Technology's recent partnership with Nvidia is expected to drive sustained growth and profitability. Read why I am upgrading MU stock to a strong buy.
- Bioelectronic chip detects vitamins C and D in saliva in under 20 minuteson April 24, 2024 at 9:39 am
Researchers at the University of São Paulo (USP) in Brazil have developed a bioelectronic chip that simultaneously detects vitamins C and D in body fluids. It is flexible and easy to see and can be ...
- Amid India’s chip push, Taiwan flags talent gaps, high import tariffon April 24, 2024 at 3:44 am
More than 90 per cent of the world’s most advanced chips required for almost all electronic equipment such as smartphones, car components, data centres, fighter jets and AI technologies, are made in ...
- Fish and chips in Calderdale: Westgate Fish Bar in Elland gains place amongst UK’s top fish and chip shopson April 24, 2024 at 2:34 am
Westgate Fish Bar in Elland has once again gained its place amongst the UK’s top fish and chip shops. For the sixth year running, through a rigorous assessment, the business has achieved the NFFF ...
- Prince George is ‘a chip off the old block’ says body language expert as she highlights the similarities between him and his dad Prince Williamon April 22, 2024 at 5:12 pm
A body language expert has highlighted the many sweet similarities between Prince William and his son Prince George, saying the youngster is ‘like a chip off the old block.’ ...
via Google News and Bing News